Female infertility. Female infertility associated with anovulation
Conditions
Interventions
Intervention 1: " :Intervention group: " herbal medicine (Mixture) 700 mgs/day continuous for 3 cycles. Intervention 2: "Control group" Clomiphene Citrate 50-150 mg for 3 cycles. Intervention 3: '' :I
Sponsors
Vice chancellor for Research,Tabriz University Of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 35 Years
Inclusion criteria
Inclusion criteria: willing to participate in the study having at least two out of three of the Rotterdam criteria (2003) for the diagnosis of PCOS aged between 18–35 years old having body mass index (BMI) less than 30 not receiving any treatment at least in the last 3 months (wash out)
Exclusion criteria
Exclusion criteria: patients with diabetes mellitus use of medications such as those helping ovulation or insulin sensitizers thyroid disorders cholesterol-lowering drugs smoking hypertension cardiovascular diseases Cushing syndrome allergy to Mentha spicata (spearmint), Zingiber officinale (ginger) ,Cinnamomum zeylanicum (cinnamon), and Citrus Sinensis (sweet orange)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Treatment of ovarian cysts. Timepoint: Before the intervention, three months after intervention. Method of measurement: Ultrasound of the ovaries (ovarian size, number and size of follicles). | — |
Secondary
| Measure | Time frame |
|---|---|
| Pregnancy. Timepoint: 3 months after taking medicinal plants (Citro Plus). Method of measurement: Positive BhcG. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactArash Khaki
PMC Pharmaceutical International Company
Outcome results
None listed